Literature DB >> 1655489

Effects of mastoparan and related peptides on phosphoinositide breakdown in HL-60 cells and cell-free preparations.

F Gusovsky1, D G Soergel, J W Daly.   

Abstract

In differentiated HL-60 cells the amphiphilic peptide mastoparan induces a dose-dependent stimulation of phosphoinositide breakdown with an EC50 value of 9 microM. Such stimulation can be markedly reduced by pretreatment of the cells with pertussis toxin (100 ng/ml, 2 h). In membranes obtained from differentiated HL-60 cells, guanine nucleotides stimulate the formation of IP2 and IP3. Calcium ions also induce phosphoinositide breakdown in this preparation independent of the presence of guanine nucleotides. In HL-60 cell membranes, mastoparan inhibited GTP gamma S-stimulation of phosphoinositide breakdown with an IC50 value of 3 microM. Such inhibitory activity of mastoparan also was present in membranes from cells pretreated with pertussis toxin. Calcium-induced stimulation of phosphoinositide breakdown was not significantly inhibited by mastoparan. The analogs mastoparan-X and polistes mastoparan had similar inhibitory activity, whereas the analog des-Ile1-Asn2-mastoparan was inactive. In permeabilized HL-60 cells mastoparan also inhibited phosphoinositide breakdown. Another amphiphilic peptide, melittin, was inactive in HL-60 intact cells, but similar to mastoparan, inhibited guanine nucleotide-induced phosphoinositide breakdown in HL-60 cell membranes and permeabilized cells. Thus, mastoparan peptides can stimulate phosphoinositide breakdown in intact HL-60 cells, probably through the interaction with a guanine nucleotide binding protein. In permeabilized cells and in cell membranes, mastoparan induces inhibition of guanine nucleotide-mediated phosphoinositide breakdown presumably through an interaction with an intracellular site. The inhibitory action of mastoparan and melittin is probably related to the amphiphilic character of these peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655489     DOI: 10.1016/0922-4106(91)90115-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Characterization of the second messengers involved in 1α,25-dihydroxyvitamin D(3) stimulated intestinal calcium absorption (transcaltachia).

Authors:  L X Zhou; A W Norman
Journal:  Endocrine       Date:  1996-08       Impact factor: 3.633

2.  Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells.

Authors:  N Nakahata; H Ishimoto; K Mizuno; Y Ohizumi; H Nakanishi
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

3.  Mastoparan-induced phosphatidylcholine hydrolysis by phospholipase D activation in human astrocytoma cells.

Authors:  K Mizuno; N Nakahata; Y Ohizumi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

4.  Mastoparan may activate GTP hydrolysis by Gi-proteins in HL-60 membranes indirectly through interaction with nucleoside diphosphate kinase.

Authors:  J F Klinker; A Hagelüken; L Grünbaum; I Heilmann; B Nürnberg; R Harhammer; S Offermanns; I Schwaner; J Ervens; K Wenzel-Seifert
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

5.  Mastoparan binds to glycogen phosphorylase to regulate sarcoplasmic reticular Ca2+ release in skeletal muscle.

Authors:  Yutaka Hirata; Masanori Atsumi; Yasushi Ohizumi; Norimichi Nakahata
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

6.  Effects of the amphiphilic peptides mastoparan and adenoregulin on receptor binding, G proteins, phosphoinositide breakdown, cyclic AMP generation, and calcium influx.

Authors:  Y Shin; R W Moni; J E Lueders; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1994-04       Impact factor: 5.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.